Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects
Year: 2002
Type: article
Institutions: University of Pennsylvania, Novartis (Switzerland)
Language: English
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Novartis, Novartis Pharma
OpenAlex ID: W2046286465
